Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-DOPA and Exercise for Late-Life Depression
NCT04650217Phase 4Terminated
- Sponsor
- New York State Psychiatric Institute
- Start
- Oct 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levodopa in major depressive disorder (MDD), sponsored by New York State Psychiatric Institute. Started Oct 2021; status: terminated.
02
Drugs
levodopa
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04650217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04650217.